Australia markets close in 2 hours 38 minutes

MedMen Enterprises Inc. (0JS.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.00940.0000 (0.00%)
At close: 12:05PM CEST
Full screen
Previous close0.0094
Open0.0094
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0094 - 0.0094
52-week range0.0069 - 0.0360
Volume0
Avg. volume0
Market cap14.204M
Beta (5Y monthly)1.42
PE ratio (TTM)N/A
EPS (TTM)-0.1000
Earnings date24 May 2024 - 28 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    MedMen Announces Management and Board Changes

    BOCA RATON, Fla., January 24, 2024--MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company, today announced that Ellen Deutsch Harrison has stepped down as the Chief Executive Officer and a Board member effective January 19, 2024 and the Board has appointed Richard Ormond as Chief Restructuring Officer. Furthermore, Michael Serruya, Executive Chairman of the Board, who has served on the Board since August 2021, has stepped down from the Board e

  • Business Wire

    MedMen Exits Arizona Market, Completing Sale of Local Operations to MINT Cannabis

    BOCA RATON, Fla., January 05, 2024--MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, today announced that the Company has completed the previously announced sale of its non-core business operations in Arizona to an affiliate of Mint Cannabis ("MINT Cannabis"). The pending sale of the Company’s assets in Nevada to MINT Cannabis awaits regulatory approval for completion.

  • Business Wire

    MedMen Provides Annual Filing Status Report

    BOCA RATON, Fla., December 21, 2023--MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, is providing this bi-weekly default status report in accordance with National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"). On November 2, 2023, the Company announced that it had been granted a management cease trade order against the Company’s CEO and CFO ("MCTO") by its principal regulator, the B